204 related articles for article (PubMed ID: 32035752)
1. Comprehensive metabolic flux analysis to explain skeletal muscle weakness in COPD.
Engelen MPKJ; Jonker R; Thaden JJ; Ten Have GAM; Jeon MS; Dasarathy S; Deutz NEP
Clin Nutr; 2020 Oct; 39(10):3056-3065. PubMed ID: 32035752
[TBL] [Abstract][Full Text] [Related]
2. Sex related differences in muscle health and metabolism in chronic obstructive pulmonary disease.
Engelen MPKJ; Kirschner SK; Coyle KS; Argyelan D; Neal G; Dasarathy S; Deutz NEP
Clin Nutr; 2023 Sep; 42(9):1737-1746. PubMed ID: 37542951
[TBL] [Abstract][Full Text] [Related]
3. Increased amino acid turnover and myofibrillar protein breakdown in advanced cancer are associated with muscle weakness and impaired physical function.
van der Meij BS; Deutz NEP; Rodriguez RER; Engelen MPKJ
Clin Nutr; 2019 Oct; 38(5):2399-2407. PubMed ID: 30477932
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in COPD-related quadriceps muscle dysfunction and fibre abnormalities.
Sharanya A; Ciano M; Withana S; Kemp PR; Polkey MI; Sathyapala SA
Chron Respir Dis; 2019; 16():1479973119843650. PubMed ID: 31131626
[TBL] [Abstract][Full Text] [Related]
5. Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease.
Jonker R; Deutz NE; Erbland ML; Anderson PJ; Engelen MP
Am J Clin Nutr; 2016 Jun; 103(6):1458-64. PubMed ID: 27146652
[TBL] [Abstract][Full Text] [Related]
6. Disturbances in branched-chain amino acid profile and poor daily functioning in mildly depressed chronic obstructive pulmonary disease patients.
Pinson MR; Deutz NEP; Harrykissoon R; Zachria AJ; Engelen MPKJ
BMC Pulm Med; 2021 Nov; 21(1):351. PubMed ID: 34743729
[TBL] [Abstract][Full Text] [Related]
7. Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients.
Ferrari R; Caram LM; Faganello MM; Sanchez FF; Tanni SE; Godoy I
Int J Chron Obstruct Pulmon Dis; 2015; 10():1553-8. PubMed ID: 26345641
[TBL] [Abstract][Full Text] [Related]
8. Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease.
Rutten EP; Franssen FM; Engelen MP; Wouters EF; Deutz NE; Schols AM
Am J Clin Nutr; 2006 Apr; 83(4):829-34. PubMed ID: 16600935
[TBL] [Abstract][Full Text] [Related]
9. Reduced HDAC2 in skeletal muscle of COPD patients.
To M; Swallow EB; Akashi K; Haruki K; Natanek SA; Polkey MI; Ito K; Barnes PJ
Respir Res; 2017 May; 18(1):99. PubMed ID: 28526090
[TBL] [Abstract][Full Text] [Related]
10. The phosphodiesterase-4 inhibitor roflumilast reverts proteolysis in skeletal muscle cells of patients with COPD cachexia.
Barreiro E; Puig-Vilanova E; Salazar-Degracia A; Pascual-Guardia S; Casadevall C; Gea J
J Appl Physiol (1985); 2018 Aug; 125(2):287-303. PubMed ID: 29648516
[TBL] [Abstract][Full Text] [Related]
11. Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease.
Diao W; Labaki WW; Han MK; Yeomans L; Sun Y; Smiley Z; Kim JH; McHugh C; Xiang P; Shen N; Sun X; Guo C; Lu M; Standiford TJ; He B; Stringer KA
Int J Chron Obstruct Pulmon Dis; 2019; 14():2015-2025. PubMed ID: 31564849
[TBL] [Abstract][Full Text] [Related]
12. Limb muscle dysfunction in COPD: effects of muscle wasting and exercise training.
Franssen FM; Broekhuizen R; Janssen PP; Wouters EF; Schols AM
Med Sci Sports Exerc; 2005 Jan; 37(1):2-9. PubMed ID: 15632660
[TBL] [Abstract][Full Text] [Related]
13. Relation between upper-limb muscle strength with exercise capacity, quality of life and dyspnea in patients with severe chronic obstructive pulmonary disease.
Kaymaz D; Candemir İÇ; Ergün P; Demir N; Taşdemir F; Demir P
Clin Respir J; 2018 Mar; 12(3):1257-1263. PubMed ID: 28618190
[TBL] [Abstract][Full Text] [Related]
14. Muscle Oxidative Capacity Is Reduced in Both Upper and Lower Limbs in COPD.
Adami A; Corvino RB; Calmelat RA; Porszasz J; Casaburi R; Rossiter HB
Med Sci Sports Exerc; 2020 Oct; 52(10):2061-2068. PubMed ID: 32282451
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: results from the DICES trial.
Sillen MJ; Franssen FM; Delbressine JM; Vaes AW; Wouters EF; Spruit MA
Thorax; 2014 Jun; 69(6):525-31. PubMed ID: 24399630
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease.
Rutten EP; Engelen MP; Wouters EF; Schols AM; Deutz NE
Am J Clin Nutr; 2006 Jan; 83(1):115-23. PubMed ID: 16400059
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction.
Barreiro E; Peinado VI; Galdiz JB; Ferrer E; Marin-Corral J; Sánchez F; Gea J; Barberà JA;
Am J Respir Crit Care Med; 2010 Aug; 182(4):477-88. PubMed ID: 20413628
[TBL] [Abstract][Full Text] [Related]
18. Presence or Absence of Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease is Associated With Distinct Phenotypes.
Cruthirds CL; van der Meij BS; Wierzchowska-McNew A; Deutz NEP; Engelen MPKJ
Arch Bronconeumol (Engl Ed); 2021 Apr; 57(4):264-272. PubMed ID: 32115277
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of quadriceps muscle weakness in patients with COPD and its association with disease severity.
Kharbanda S; Ramakrishna A; Krishnan S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1727-35. PubMed ID: 26366065
[TBL] [Abstract][Full Text] [Related]
20. Metabolic phenotyping using kinetic measurements in young and older healthy adults.
Deutz NEP; Thaden JJ; Ten Have GAM; Walker DK; Engelen MPKJ
Metabolism; 2018 Jan; 78():167-178. PubMed ID: 28986165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
